Abstract Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule
Data are constantly changing and updating
In addition to dietary and pharmaceutical influences, new research confirms that GLP-1 secretion is impacted by sex as well as many personal health factors, including glucose tolerance and overall metabolic health, body weight, microbiome composition, and even eating behaviour itself (Huber et al., 2024)
And whats been interesting about it for me, and I think this sort of leads into my next question about do we do this forever
Ultimately, the choice depends on your treatment goals, tolerance, insurance coverage, and whether your priority is weight loss, cardiovascular health, or metabolic control
Other animal studies have found that GLP-1R agonists reduce amphetamine use and amphetamine-induced hyperlocomotion